Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients

Background: Scarce data exist that analyze the outcomes of hematological patients with SARS-CoV-2 infection during the Omicron variant period who received treatment with remdesivir or nirmatrelvir/ritonavir. Methods: This study aims to address this issue by using a retrospective observational regist...

Descripción completa

Detalles Bibliográficos
Autores principales: Piñana, José Luis, Heras, Inmaculada, Aiello, Tommaso Francesco, García-Cadenas, Irene, Vazquez, Lourdes, Lopez-Jimenez, Javier, Chorão, Pedro, Aroca, Cristina, García-Vidal, Carolina, Arroyo, Ignacio, Soler-Espejo, Eva, López-Corral, Lucia, Avendaño-Pita, Alejandro, Arrufat, Anna, Garcia-Gutierrez, Valentín, Arellano, Elena, Hernández-Medina, Lorena, González-Santillana, Clara, Morell, Julia, Hernández-Rivas, José Ángel, Rodriguez-Galvez, Paula, Mico-Cerdá, Mireia, Guerreiro, Manuel, Campos, Diana, Navarro, David, Cedillo, Ángel, Martino, Rodrigo, Solano, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612015/
https://www.ncbi.nlm.nih.gov/pubmed/37896843
http://dx.doi.org/10.3390/v15102066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612015/
https://www.ncbi.nlm.nih.gov/pubmed/37896843
http://dx.doi.org/10.3390/v15102066

Ejemplares similares